Utility of radiation therapy for early-stage uterine papillary serous carcinoma. Read more about Utility of radiation therapy for early-stage uterine papillary serous carcinoma.
Cervical cancer screening in women over 65. CON: Reasons for uncertainty. Read more about Cervical cancer screening in women over 65. CON: Reasons for uncertainty.
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Read more about A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.
Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery. Read more about Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery.
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Read more about No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N. Read more about Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications. Read more about Post-operative enteral immunonutrition for gynecologic oncology patients undergoing laparotomy decreases wound complications.
Comprehensive care in gynecologic oncology: The importance of palliative care. Read more about Comprehensive care in gynecologic oncology: The importance of palliative care.
Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Read more about Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.
